Published in Medical Verdicts and Law Weekly, June 21st, 2007
These are the first reported results from a late-stage development program consisting of single-agent studies and planned Phase III trials in combination with common chemotherapy regimens in several...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.